The invention provides an isolated antibody or antibody fragment thereof that binds an extracellular epitope of a fibroblast
growth factor receptor-4 (FGFR4) that is expressed by mammalian cells and inhibits cancer cell invasion. Optionally, the
antibody or fragment thereof binds an epitope of FGFR4 that is bound ...
Documents
Form STK-2-21022018-signed
-20052017
Optional Attachment-(1)-20052017
-25042017
Evidence of cessation;-07062016
Form DIR-12-07062016_signed
Notice of resignation;-07062016
Optional Attachment-(1)-07062016
Optional Attachment-(2)-07062016
Form AOC-4-271215.OCT
Form ADT-1-261215.OCT
Form MGT-7-101215.OCT
Form DIR-12-081215.OCT
Declaration of the appointee Director- in Form DIR-2-081215.PDF